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Background/Introduction
Tumor histology and stage are predictors of survival in
patients with malignant pleural mesothelioma (MPM).
The TNM classification that is widely accepted for
MPM has its limitations. Significance of tumor volume,
a better representation of tumor burden is not routinely
determined. We hypothesized tumor volume is a better
predictor of survival and complimentary to T and N
stage. Extended pleurectomy and decortication (EPD), a
lung sparing procedure, provides an opportunity to mea-
sure the tumor volume and pathological stage.
Aims/Objectives
Evaluate the significance of tumor volume on overall
survival in patients undergoing EPD for MPM.
Method
111 patients who underwent EPD for MPM formed the
basis of this report. The following variables were
assessed: age, gender, histology including percent epithe-
lioid histology and pathological T and N stage. Tumor
volume of resected specimens was measured using a
water displacement method. A Cox regression model
was used to identify significant predictors of survival.
Kaplan-Meier was used to summarize overall and sub-
group survival.
Results
There were 91 males and 20 females with a median age
of 68 years (range 43-88 years). Median tumor volume
was 560 ml (range 100-2200 ml). Tumor volume was
less than 300 ml in 18 patients, between 301-600cc in
37 patients, 601-900 in 29 patients and >900cc in 25
patients. Five patients (4.5%) died within 30 days of sur-
gery. Overall two year survival from diagnosis was 48.3%
and from EPD was 31.5%. Tumor volume was a signifi-
cant predictors of survival (p = 0.001, Table 1) and T
stage (p = 0.05). No relationship between N stage and
either tumor volume or histology was observed.
Discussion/Conclusion
Tumor volume is an independent predictor of survival
in patients with MPM undergoing EPD.
Tumor volume is an important measure and is com-
plimentary to TNM staging.
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Table 1
Volume Median survival
<300 ml 2.25 years
301-600 ml 1.62 years
601-900 ml 1.06 years
> 900 ml 0.9 years
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